Basket cover image
7 handpicked stocks

7 Stocks with Dual Potential

This collection features companies that offer two ways to grow your money. Professional analysts predict these stocks will increase in value while also rewarding shareholders with regular dividend payments. It's like getting the best of both worlds!

stock
stock
stock
stock
stock
stock
stock
Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at मई 10

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

PFE

Pfizer Inc.

PFE

Current price

$25.32

UPS

United Parcel Service, Inc.

UPS

Current price

$87.80

EPD

Enterprise Products Partners L.P.

EPD

Current price

$31.41

About This Group of Stocks

1

Our Expert Thinking

These large companies (all with $10+ billion market cap) offer investors a valuable double opportunity. They combine the potential for significant price growth in the next 12 months with consistent dividend income, creating a balanced approach that works for many investment strategies.

2

What You Need to Know

Each company in this group has a strong forecast for price appreciation (shown as Potential Profit %) and pays dividends (shown as Dividend Yield %). This combination can be especially appealing during uncertain market conditions, offering both growth potential and income.

3

Why These Stocks

Our analysts selected these specific companies because they demonstrate market stability while still offering growth opportunities. They have established business models, strong financial positions, and the ability to generate consistent revenue that supports both share price growth and dividend payments.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+43.69%

Group Performance Snapshot

43.69%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 43.69% over the next year.

4 of 7

Stocks Rated Buy by Analysts

4 of 7 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

💰

Double Your Money Chances

These unique picks offer two possible ways to profit instead of just one. If the stock price rises as analysts predict, you win. If they pay their expected dividends, you win again.

🏢

Big Names, Big Potential

Large companies with $10+ billion market caps tend to be more stable during uncertain times. These established businesses have the resources to weather economic storms while still growing.

📊

Backed by Expert Analysis

Professional analysts have identified these specific stocks as having significant growth potential over the next 12 months, giving you confidence that these aren't random picks.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Orphan Drug Moats: Leaders In Rare Disease

Orphan Drug Moats: Leaders In Rare Disease

The FDA's rejection of PTC Therapeutics' drug for a rare genetic disorder has delayed a new treatment option and created a significant setback for the company. This regulatory decision strengthens the competitive position of companies with already-approved therapies for rare diseases, highlighting the value of a proven drug portfolio.

View stocks
Nvidia's China Chip Pivot

Nvidia's China Chip Pivot

Nvidia is developing a new, compliant AI chip for China, aiming to recapture market share lost to U.S. export controls. This strategic pivot creates a ripple effect, potentially benefiting the entire semiconductor supply chain that supports the production and deployment of this advanced hardware.

View stocks
Navigating The Autonomous Driving Shakeout

Navigating The Autonomous Driving Shakeout

A class-action lawsuit against Tesla regarding its Full Self-Driving claims puts the company's marketing and technology under intense scrutiny. This legal challenge could boost demand for competing autonomous driving technologies, creating opportunities for companies that supply advanced sensors and software.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.